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A B S T R A C T
Background and purpose: One psychopathological mechanism that links anger to coronary artery disease
(CAD) is cardiac autonomic imbalance. Blood volume amplitude (BVA) and pulse transit time (PTT) are
related to peripheral arterial elasticity and cardiac conduction, which are used as indirect markers for
autonomic activation. The purposes of this study were to examine the relationships between BVA and
PTT, and the reactivity of BVA and PTT during the anger recall task in patients with CAD.
Methods and subjects: A total of 112 patients with CAD and 93 healthy controls were recruited; BVA and
PTT were collected during baseline, the neutral episode, the anger episode, and after recovery.
Results: There were signiﬁcant positive correlations between BVA and PTT in all participants. BVA
reactivity during the anger episode was greater in patients with CAD than in healthy controls, and there
were also lower BVA recovery values after the neutral and anger episodes. However, there was no
signiﬁcant difference in BVA reactivity between the two groups in the neutral episode. PTT recovered to
baseline levels after the neutral and anger episodes in healthy controls, but not in the patients with CAD.
Conclusion: BVA and PTTwere associatedwith peripheral vascular elasticity and cardiac conduction that
were regulated by the cardiac autonomic system. Peripheral vasoconstriction and changes in travel time
between left ventricular and peripheral vasculature during the anger episode, and impaired recovery to
baseline levels may relate to the psychopathological mechanisms of CAD.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.Introduction
Photoplethysmographic blood volume pulse (BVP) is a nonin-
vasive sensor and is used to measure blood volume changes and
vasodilator function in themicrovessels of the ﬁnger. BVP is widely
used to detect the peripheral pulse waveform that is converted to
blood volume amplitude (BVA) (Fig. 1). BVA reﬂects arterial
dilation and contraction that are controlled by the autonomic
nervous system (ANS) [1,2]. Shelley [2] indicated that increasing
sympathetic nervous system (SNS) activation contracts the
microvessels of the ﬁnger, decreasing BVA. On the other hand,
increasing parasympathetic nervous system (PNS) activation
dilates the microvessels of the ﬁnger, increasing BVA. A previous* Corresponding author at: 100, Shiquan 1st Rd., Kaohsiung 807, Taiwan.
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0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsstudy found that BVA was inﬂuenced by endothelial function and
reﬂected peripheral vasomotor function in patients with athero-
sclerosis [3]. After unilateral cuff occlusion, participants who had
peripheral arteriosclerosis or endothelial dysfunction had a lower
BVA during reactive hyperemia than at baseline. Therefore, BVA
was considered to be an independent marker for myocardial
infarction and cardiovascular disease [4–7].
Pulse transit time (PTT) is the time interval between ventricular
depolarization and arrival of the peripheral pulse wave at the
ﬁnger pad. PTT is determined by the R-wave on an electrocardio-
gram (ECG) and the peak of the pulse wave on a ﬁnger BVP sensor,
and is an indirect index of the ANS [1,8]. Naschitz et al. [9] found
that PTT was negatively related to systolic blood pressure (SBP)
and diastolic blood pressure (DBP). Wagner et al. [10] found a
longer PTT in patients with heart failure than in healthy volunteers
(468  12 ms and 430  23 ms, respectively). The reason that the PTT
was prolonged in patients with heart failure remains unknown, but
possible reasons include a longer ventricular depolarization, lowreserved.
[(Fig._1)TD$FIG]
Fig. 1. Pulse transit time (PTT) (top) and blood volume amplitude (BVA) (bottom) at various experimental stages.
I.-M. Lin et al. / Journal of Cardiology 65 (2015) 50–56 51ejection fraction, longer time for arrival to the ﬁnger pad, and higher
levels of peripheral arterial resistance [10].
Anger has been related to hyperactivity of the cardiovascular
response and autonomic activation that likely increases morbidity
and mortality among patients with coronary artery disease (CAD)
[11]. Anger triggers acute myocardial infarction onset [12,13], and
the relative risk of myocardial infarction was found to be 9.0 after
1 h of an anger episode [14]. The anger recall task is a stress task
with high ecological validity and is used widely to explore the
cardiovascular responses in patients with CAD [15,16] and in
healthy controls [17–20]. For example, Boltwood et al. [16] asked
12 patients with myocardial ischemia to recall an anger event and
measured the diameter of arteries during cardiac catheterization.
They found that patients with previously narrowed coronary
arteries had increased vasoconstriction compared to patients
without narrowed coronary arteries in the anger episode. Why
et al. [19] compared the reactivity of heart rate, blood pressure, and
total peripheral resistance between baseline, mental arithmetic,
number reading, and the anger recall task in male patrol ofﬁcers;
signiﬁcantly, higher blood pressure and total peripheral resistance
were found during the anger recall task than during the other tasks.
It remains unknown whether patients with CAD have lower
BVA and prolonged PTT responses during an anger episode
compared to healthy controls, or whether BVA and PTT can be
indirect indices of SNS activation. Therefore, the purposes of this
study were to examine (1) the relationships between BVA, PTT,
heart rate, blood pressure, and SNS activation and (2) the
differences in BVA reactivity and the PTT value during neutral
and anger tasks between patients with CAD and healthy controls.
Methods
Participants
Patients with CAD and healthy controls were recruited.
Inclusion criteria for patients with CAD were as follows: (a) a
blockage of greater than 50% in the left main artery or 75% in the
left anterior descending, left circumﬂex, and right coronary
arteries, identiﬁed by coronary angiography or (b) a history ofcoronary intervention such as angioplasty, stent, laser, or coronary
artery bypass surgery [21]. Patients who had pacemakers,
arrhythmias, severe physical illnesses, or mental disorders were
excluded. The inclusion criteria for healthy controls were a lack of
physical illness or mental disorder and not taking medication.
Participants in either group who had rotating work shifts were
excluded. Institutional Review Board approval was obtained from
the ethics committee of Kaohsiung Medical University Hospital.
Full explanation was given and written informed consent was
obtained from all participants before the study.
Psychophysiological measures
A GE Marquette SmartPac Tram transport display (Absolute
Medical Equipment, Garnerville, NY, USA) was used to collect
blood pressure data at 2-min intervals. The BioGraph InﬁnitiTM
version 5.0.3 (Thought Technology Ltd., Montre´al West, Que´bec,
Canada) with sampling rates of 2048/s, lead II ECG placement, and
a BVP sensor was attached to the thumb and used to collect the
physiological data. Three well-trained research assistants used the
same experimental protocol to collect the raw signals; they were
supervised by two cardiologists and a clinical psychologist with
the certiﬁcation of Biofeedback Certiﬁcation International Alliance
tomake sure the validity and accuracy of measurement of BVA and
PTT. Demographic data were collected, including age, gender, and
height; a medical record was obtained that included information
regarding coronary intervention, and medications; a health
behavior questionnaire was administered, which included ques-
tions about smoking, exercise frequency, and duration. Chinese
Hostility Inventory-Short Form [22] and Beck Depression Invento-
ry-II [23] were used to measure hostility and depression as the
psychosocial risk factors of CAD.
Data reduction
The BVA was converted from BVP signals and analyzed by using
BioGraph InﬁnitiTM. PTT was acquired from the time interval
between the peak of the R-wave on the ECG and the arrival to the
ﬁnger pad, asmeasuredbyaBVPsensor. BVA andPTTwere analyzed
and excluded from the statistic analysis when BVA or ECG artifacts
Table 1
The demographic data and research variables.
CAD (n=112) Healthy controls (n=93) t/x2
Age (years) 59.81 (10.53) 59.67 (13.46) 0.09
Gender (male/female) 93/19 69/24 2.40
Height (cm) 164.68 (7.42) 164.26 (7.61) 0.38
Smoking 0.47 (1.09) 0.40 (0.99) 0.46
Exercise frequency 1.93 (1.17) 1.72 (1.05) 1.33
Exercise duration 1.67 (1.07) 1.90 (1.03) 1.53
Hostility 50.19 (13.12) 48.12 (12.19) 1.15
Depression 8.12 (10.91) 5.13 (6.42) 1.65
Beta-blocker 67 (59.8%) –
Anti-lipid 69 (61.6%) –
Angiotensin-converting
enzyme inhibitor
47 (42.0%) –
Nitroglycerin 29 (25.9%) –
Calcium channel blockers 43 (38.4%) –
Diuretic 28 (25.0%) –
Heart rate (bmp) 68.07 (9.49) 72.32 (9.55) 3.00**
SBP (mmHg) 134.72 (17.92) 127.79 (14.50) 2.94**
DBP (mmHg) 72.25 (10.91) 71.67 (11.28) 0.37
BVA
Baseline 10.32 (4.94) 6.52 (3.24) 6.61***
Neutral 8.31 (4.35) 4.92 (2.60) 6.70***
Recovery I 8.49 (4.65) 5.40 (2.87) 5.78***
Anger 6.80 (3.90) 4.32 (2.38) 5.11***
Recovery II 6.87 (4.38) 4.19 (2.78) 5.28***
PTT (ms)
Baseline 370.62 (51.28) 342.95 (45.55) 4.05***
Neutral 368.72 (52.67) 342.29 (46.82) 3.67***
Recovery I 371.77 (54.23) 348.86 (45.72) 3.22**
Anger 374.44 (52.44) 344.77 (42.34) 4.01***
Recovery II 371.89 (52.89) 349.54 (46.90) 3.15**
BVA, blood volume amplitude; CAD, coronary artery disease; DBP, diastolic
blood pressure; PTT, pulse transit time; SBP, systolic blood pressure.
** p<0.01.
*** p<0.001.
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subtracting the baseline value from the values of each experimental
stage, such as d_N-B (neutral subtract baseline), d_RI-B (recovery I
subtract baseline), d_A-B (anger recall subtract baseline), and d_RII-
B (recovery II subtract baseline). Heart rate was acquired from
interbeat intervals of raw ECG signals. A CardiacPro Inﬁniti HRV
analysis module (Thought Technology) with fast Fourier transform
was used to acquire the SNS index: the low frequency (0.04–
0.15 Hz)/high frequency (0.15–0.4 Hz) ratio (LF/HF ratio) [24].
Experimental protocol
All participants were instructed to refrain from caffeine,
alcohol, tobacco, or excessive exercise for 3 h prior to the
experimental protocol. Participants were seated in a sound-
attenuated and temperature-controlled room to ﬁll out the
questionnaires. After 10 min of sitting and resting, participants
were administered the following experimental stages in which
ECG, photoplethysmogram, and blood pressureweremeasured: (a)
baseline (5 min), wherein participants were relaxed and comfort-
ably seated; (b) a neutral recall task (6 min), including a 1-min
recall and a 5-min report of a neutral event (which was a
nonemotional and routine event, e.g. ‘‘Please tell me what you did
yesterday’’); (c) recovery I (5 min), wherein participants were
relaxed and seated comfortably; (d) an anger recall task (6 min),
including a 1-min recall and a 5-min report of an anger event that
occurred in the past 6 months (the protocol was based on previous
studies, e.g. ‘‘Please tell me about an anger event, including what
happened? Who made you feel angry? What were your feelings
and thoughts about it? And what was your response to the anger
event?’’) [19,20]; and (e) recovery II (10 min), wherein participants
were relaxed and seated comfortably.
Statistical analysis
The means and standard deviations of demographic data and
psychophysiological data were scored, analyzed, and compared
between the two groups. Pearson’s correlations coefﬁcients were
obtained for physiological data (BVA, PTT, heart rate, SBP, DBP, and
SNS index). Two-way analyses of covariance (ANCOVA), control-
ling for heart rate, SBP, and beta-blocker use were used to examine
the group differences (patients with CAD vs. healthy controls) in
BVA and PTT at various experimental stages. For controlling the
group differences at baseline for BVA, t-tests were used to examine
the reactivity of BVA (the changes in values between each
experimental stage and baseline) in patients with CAD and healthy
controls. One-way analyses of covariance (ANCOVA), controlling
for heart rate, SBP, and beta-blocker use, were used to examine the
differences in BVA and PTT at various experimental stages in
patients with CAD and healthy controls.Table 2
The correlations between BVA, PTT, heart rate, blood pressure, and SNS index (N=205
BVA
Baseline Neutral Recovery I Anger Recovery
PTT 0.18** 0.15* 0.15* 0.15y 0.11y
Heart rate 0.17* 0.22** 0.21** 0.21* 0.13y
SBP 0.06 0.00 0.01 0.08 0.03
DBP 0.11 0.12 0.16* 0.11 0.12
SNS index 0.04 0.07 0.08 0.01 0.01
BVA, blood volume amplitude; DBP, diastolic blood pressure; PTT, pulse transit time
* p<0.05.
** p<0.01.
*** p<0.001.
y p<0.10.The effect sizes of the partial eta squared (h2p) were calculated in
two-way ANCOVA and one-wayANCOVA in BVA and PTT at various
experimental stages for both groups: an h2p of 0.01–0.05
represented a small effect size, an h2p of 0.06–0.14 represented a
medium effect size, and an h2p>0:14 represented a large effect size
[25]. All statistics were performed using version 18.0 of SPSS
predictive analytics software statistics (SPSS Inc., Chicago, IL, USA).
Results
Participant characteristics
The mean age of the 112 patients with CAD was 59.81 years
(SD = 10.53), and 83.04% were male; the mean age of the 93
healthy controls was 59.67 years (SD = 13.46), and 74.19% were
male. There were no signiﬁcant differences between the two).
PTT
II Baseline Neutral Recovery I Anger Recovery II
0.51*** 0.53*** 0.52*** 0.50*** 0.53***
0.12 0.01 0.06 0.16* 0.08
0.01 0.01 0.05 0.02 0.05
0.15* 0.14y 0.14y 0.20* 0.11
; SBP, systolic blood pressure; SNS, sympathetic nervous system.
[(Fig._2)TD$FIG]
Fig. 2. Blood volume amplitude (BVA) at various experimental stages (top), and the reactivity of BVA (bottom) in patients with coronary artery disease (CAD) or healthy
controls.
Table 3
The BVA and PTT at various experimental stages in patients with CAD and healthy controls.
Variables Group Baseline (B) Neutral (N) Recovery I (RI) Anger (A) Recovery II (RII) Time Group Time* group Effect size (h2p) Post hoc comparison
BVAa Healthy
controls
7.30 (2.86) 5.33 (2.59) 5.98 (2.56) 4.30 (2.49) 4.47 (2.58) 1.69 10.07** 2.71* 0.02 B>N, RI, A, RII; RI>N;
N>A, RII; RI>A, RII
CAD 11.08 (4.71) 8.94 (4.01) 9.19 (4.44) 6.98 (3.87) 7.59 (4.33)
PTT a
(ms2)
Healthy
Controls
354.12 (42.68) 352.77 (44.72) 360.44 (40.42) 346.17 (41.87) 358.73 (43.81) 0.24 0.36 1.18 0.01
CAD 374.55 (49.67) 371.60 (50.06) 372.92 (51.49) 372.11 (53.52) 372.37 (51.97)
PTT b
(ms2)
Healthy
Controls
347.12 (45.48) 347.10 (46.33) 354.49 (46.04) 344.42 (42.21) 354.68 (47.58) 2.77* 0.04 RI>N; RI, RII>A
PTT b
(ms2)
CAD 372.92 (49.71) 372.26 (50.49) 372.86 (52.76) 373.67 (52.18) 373.40 (51.61) 0.07 <0.01
* p<0.05.
** p<0.01.
a Two-way ANCOVA with controlling the heart rate, SBP, and beta-blocker used.
b One-way ANOVA to examine the PTT at various experimental stages; BVA, blood volume amplitude; CAD, coronary artery disease; PTT, pulse transit time.
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height (t = 0.38, p > 0.05), exercise frequency (t = 1.33, p > 0.05), or
exercise duration (t = 1.53, p > 0.05). However, there were
signiﬁcant differences between the two groups in heart rate and
SBP at baseline (t = 3.00, p < 0.01; t = 2.94, p < 0.01, respectively)
(Table 1).
Correlations between BVA, PTT, cardiovascular response, and SNS
index
There were signiﬁcant positive correlations between BVA and
PTT at the baseline, neutral, and recovery I stages (r = 0.18,
p < 0.01; r = 0.15, p < 0.05; r = 0.15, p < 0.05, respectively) in all
participants. There were signiﬁcant negative correlations between
BVA and heart rate at the baseline, neutral, recovery I, and anger
stages (r = 0.17, p < 0.05; r = 0.22, p < 0.01; r = 0.21, p < 0.01;
and r = 0.21, p < 0.01, respectively), as well as a negative
correlation between BVA and DBP at recovery I (r = 0.16,
p < 0.05). However, there was no signiﬁcant correlation between
BVA and SBP, as well as no signiﬁcant correlation between BVP and
SNS index (Table 2).
There were signiﬁcant negative correlations between PTT and
heart rate at all experimental stages (r = 0.50 to0.53, p < 0.001),
as well as a positive correlation between PTT and SBP during the
anger episode (r = 0.16, p < 0.05). There were positive correlations
between PTT and SNS index at the baseline and anger stages
(r = 0.15, p < 0.05; r = 0.20, p < 0.05, respectively) (Table 2).
Lower blood volume amplitude during the anger episode than during
the neutral episode in patients with CAD
After controlling for heart rate, SBP, and beta-blocker use, there
was a signiﬁcant interaction effect between the twogroups inBVAat
various experimental stages (F = 2.71, p < 0.05; effect size = 0.02).
The post hoc comparison found that BVAwas lower during the anger
episode than during baseline and the neutral episode in both groups
(Table 3). BVA values at various experimental stages were
signiﬁcantly higher in patients with CAD than in healthy controls
(F = 10.07,p < 0.05) (Table3). Therefore, this studyused reactivityof
BVA to control the baseline differences between the two groups, and
the results found a higher reactivity of BVA (peripheral blood vessel
constrictions) in patients with CAD than in healthy controls in the
anger episode, and in recovery I and II (t = 2.64, p < 0.01; t = 2.43,
p < 0.05; t = 2.81, p < 0.01, respectively), but not during the neutral
episode (t = 0.81, p > 0.05) (Fig. 2).[(Fig._3)TD$FIG]Fig. 3. Pulse transit time (PTT) at various experimental stages in paPulse transit time increased after neutral and anger episodes only in
healthy controls, not in patients with CAD
Despite higher PTT values at various experimental stages in
patients with CAD than in healthy controls (Table 1), after
controlling for heart rate, SBP, and beta-blocker use, two-way
ANCOVA analysis did not reveal any signiﬁcant interaction effect or
main effect in PTT between the two groups at various experimental
stages. Therefore, this study used one-wayANCOVA to examine the
stage differences in each group. The results showed a signiﬁcant
difference in PTT at various experimental stages in healthy controls
(F = 2.77, p < 0.05, effect size = 0.04), but not in patients with CAD
(F = 0.07, p > 0.05, effect size < 0.01) (Table 3). The post hoc
comparison found a higher PTT at recovery I than in the neutral
episode, as well as a higher PTT at recovery I and II than during the
anger episode in healthy controls (Fig. 3).
Discussion
The present study found increased peripheral blood vessel
constriction during the anger episode than during the neutral
episode, as well as slower blood vessel dilation and recovery to
baseline after neutral and anger episodes in patientswith CAD than
in healthy controls. After controlling for heart rate, SBP, and beta-
blocker use, PTT increased at the recovery stages after neutral and
anger episodes in healthy controls; however, these tendencies
were not found in patients with CAD.
There were positive correlations between BVA and PTT and
negative correlations between BVA and heart rate and PTT and
heart rate. Blood vessel dilation related to longer travel time
between ventricular electrical activity and dilation of peripheral
arteries may be because of increased PNS activation or decreased
SNS activation [10]. For example, when SNS outﬂow causes
vasoconstriction of peripheral arteries, BVA and PTT decrease and
heart rate increases. In contrast, when PNS outﬂow causes
peripheral arteries dilation, BVA and PTT increase and heart rate
decreases [1,3,10,13]. However, this study did not ﬁnd signiﬁcant
correlations between BVA and blood pressure or between PTT and
DBP; only a positive correlation between PTT and SBP during the
anger episode was found. This result may be caused by the
increasing SNS activation and the increasing SBP during the anger
episode. Despite this, Wagner et al. [10] and Naschitz et al. [9]
indicated that PTT is directly proportional to the blood pressure:
when the blood pressure rises, travel time shortens; and when thetients with coronary artery disease (CAD) or healthy controls.
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pressure changes were not consistently related to PTT changes,
which may relate to other factors, such as peripheral vascular
resistance, cardiac conduction, stroke volume, or medication [9].
Anger is the most important psychosocial risk factor in the
etiology and prognosis of CAD, and one possible mechanism is SNS
hyperactivity [9,26,27]. When an individual encounters an anger
event that elicits SNS hyperactivity, it may cause arterial
constriction, reduce BVA, decrease travel time between left
ventricular and peripheral vasculature, and shorten PTT [3,9].
BVA was decreased in the neutral and anger episodes in both
groups. However, there was a larger decrease in BVA in patients
with CAD than in healthy controls during the anger episode.
Regarding the relationship between BVA and anger, patients with
CAD encountered more constricted blood vessels in the anger
episode and lower BVA recovery values after the neutral and anger
episodes than healthy controls. This result was consistent with
those of prior studies that found lower BVA values during the
recovery stages after unilateral cuff occlusion in CAD than non-
CAD patients [28,29]. When patients with CAD experienced anger
events, their peripheral arteries constricted and then BVA
decreased, and that made dilation and recovery to baseline
difﬁcult. The mechanism may relate to reduced elasticity of
peripheral arterial walls, endothelial dysfunction, peripheral
arteriosclerosis, artery stiffening, or hemodynamic changes in
cardiovascular disease [3–5].
Regarding the relationship between PTT and anger, PTT
decreased during the anger and neutral episodes because of SNS
activation. PTT can return to baseline levels during the recovery
stage in healthy controls because of PNS activation. However,
patients with CAD may have PNS withdrawal, ventricular
contraction, or arterial wall stiffening, which may prevent their
PTT from returning to baseline levels [9,30,31]. In addition,
patients with CAD had longer PTT than healthy controls, a result
which is similar to patients with heart failure [10]. However, this
result was inconsistent with that of Naschitz et al. [9] who
indicated that shortening of PTT related to arterial stiffening and
arteriosclerosis. A possible explanationwas that the participants in
our study and in Wagner’s study [10] were under medication,
which can slow the time interval between the ventricular
depolarization and peripheral pulse waves, artery dilation, or
reduce peripheral resistance.
There are several limitations to this study. First, despite
controlling covariables such as beta-blocker use, heart rate, and
SBP in our statistical analyses, some confounding factors may have
inﬂuenced our results, such as transitional risk factors for CAD,
arterial elasticity or stiffening, or other medication used that could
inﬂuence BVP or PTT. Second, this study neither measured the
diameter nor the function of peripheral arteries, directly, during
the anger episode; therefore, the extent of constriction and dilation
in peripheral arteries remains unknown. Third, the frequency,
magnitude, and duration of exposure to anger situations are
related in increasing the responses in SNS or hypothalamic–
pituitary–adrenal axis (i.e. increase heart rate and blood pressure;
release catecholamines and cortisol; heighten inﬂammatory
activity). However, this is a cross-sectional study; only short
periods of BVA and PTT under anger episodes were measured. The
frequency and duration under anger situations will bemeasured in
a future study. Fourth, despite us obtaining raw signals of pulse
wave and ECG, some patients with CAD had premature ventricular
contractions or arrhythmias which inﬂuenced the ECG signals and
the data were deleted from statistical analysis.
To our knowledge, this is the ﬁrst report to demonstrate the
relationship between BVA and PTT under an anger episode. The
noninvasive measurement of BVA is a proﬁle similar to ﬂow-
mediated dilation and reﬂects peripheral artery and endothelialdysfunction. Decrease in BVA during an anger episode may be
caused by eliciting SNS hyperactivity in patients with CAD. The PTT
did not change during the various experimental stages in patients
with CAD; this situation may be caused by cardiac dysfunction,
arterial elasticity, and peripheral resistance. The clinical applica-
tion of BVA and PTT could be an indirect index to explore the
association between the cardiac autonomic system and anger
emotion. Some research-applied biofeedback training to increase
BVA and improve migraine headaches [32,33], and the effect of
biofeedback training for increasing BVA in CADwill be examined in
the future.
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